BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 5435066)

  • 1. Amethopterin-induced changes in the multiple forms of dihydrofolate reductase from L1210 cells.
    Harding NG; Martelli MF; Huennekens FM
    Arch Biochem Biophys; 1970 Mar; 137(1):295-6. PubMed ID: 5435066
    [No Abstract]   [Full Text] [Related]  

  • 2. Substrate and inhibitor complexes of dihydrofolate reductase from amethopterin-resistant L1210 cells.
    Neef VG; Huennekens FM
    Arch Biochem Biophys; 1975 Dec; 171(2):435-43. PubMed ID: 959
    [No Abstract]   [Full Text] [Related]  

  • 3. Dihydrofolate reductase from the L1210 R murine lymphoma. Further studies on the binding of substrates and inhibitors to the enzyme.
    Hillcoat BL; Perkins JP; Bertino JR
    J Biol Chem; 1967 Oct; 242(20):4777-81. PubMed ID: 4383525
    [No Abstract]   [Full Text] [Related]  

  • 4. Reactivation of dihydrofolate reductase inhibted by methotrexate or aminopterin.
    Jackson RC; Niethammer D; Hart LI
    Arch Biochem Biophys; 1977 Aug; 182(2):646-56. PubMed ID: 561567
    [No Abstract]   [Full Text] [Related]  

  • 5. Stabilization of dihydrofolate reductase by inhibitors in vivo and in vitro.
    Hillcoat BL; Marshall L; Gauldie J; Hiebert M
    Ann N Y Acad Sci; 1971 Nov; 186():187-208. PubMed ID: 4332034
    [No Abstract]   [Full Text] [Related]  

  • 6. Limited effectiveness of in vitro high-dose methotrexate and leucovorin to overcome resistance in L1210 leukemia cells with elevations of dihydrofolate reductase.
    Bruckner H; Rubinoff M; Waxman S
    Eur J Cancer (1965); 1980 Aug; 16(8):1057-63. PubMed ID: 6969180
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthesis of methotrexate polyglutamates in L1210 murine leukemia cells.
    Whitehead VM
    Cancer Res; 1977 Feb; 37(2):408-12. PubMed ID: 832265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved purification of tetrahydrofolate dehydrogenase from L1210 leukemia by affinity chromatography.
    Chello PL; Cashmore AR; Jacobs SA; Bertino JR
    Biochim Biophys Acta; 1972 Apr; 268(1):30-4. PubMed ID: 5018279
    [No Abstract]   [Full Text] [Related]  

  • 9. Variation of dihydrofolate reductase activity during in vitro and in vivo growth of sublines of L1210 lymphoma.
    Hillcoat BL
    J Natl Cancer Inst; 1971 Jan; 46(1):75-80. PubMed ID: 5546195
    [No Abstract]   [Full Text] [Related]  

  • 10. A fluorescent analogue of methotrexate as a probe for folate antagonist molecular receptors.
    Susten SS; Kempton RJ; Black AM; Freisheim JH
    Biochem Pharmacol; 1984 Jun; 33(12):1957-62. PubMed ID: 6732854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L1210 dihydrofolate reductase: activation and enhancement of methotrexate sensitivity.
    Duffy TH; Sato JK; Vitols KS; Huennekens FM
    Adv Enzyme Regul; 1985; 24():13-25. PubMed ID: 3835818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ion-dependent activation of dihydrofolate reductase from L1210 cells.
    Reyes P; Huennekens FM
    Biochemistry; 1967 Nov; 6(11):3519-27. PubMed ID: 5235146
    [No Abstract]   [Full Text] [Related]  

  • 13. Dihydrofolate reductase from a resistant subline of the L1210 lymphoma. Purification and properties.
    Perkins JP; Hillcoat BL; Bertino JR
    J Biol Chem; 1967 Oct; 242(20):4771-6. PubMed ID: 4964810
    [No Abstract]   [Full Text] [Related]  

  • 14. On the poor correlation between the inhibition by methotrexate of dihydrofolate reductase and of deoxynucleoside incorporation into DNA.
    Roberts D; Wodinsky I
    Cancer Res; 1968 Oct; 28(10):1955-62. PubMed ID: 5696929
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparison of dihydrofolate reductase activity in intact leukemia cells and squamous cell carcinoma.
    FitzGerald GB; Wick MM
    Anticancer Drug Des; 1989 Jun; 4(1):79-87. PubMed ID: 2757754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifolate polyglutamylation and competitive drug displacement at dihydrofolate reductase as important elements in leucovorin rescue in L1210 cells.
    Matherly LH; Barlowe CK; Goldman ID
    Cancer Res; 1986 Feb; 46(2):588-93. PubMed ID: 2416428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dihydrofolate reductase activity and loss of resistance in an antifolate-resistant subline of leukemia L1210 after discontinuation of treatment.
    Schrecker AW; Mead JA; Greenberg NH; Goldin A
    Chem Biol Interact; 1970 Oct; 2(3):229-34. PubMed ID: 5289825
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthesis of a fluorescent derivative of amethopterin,
    Gapski GR; Whiteley JM; Rader JI; Cramer PL; Henderson GB; Neef V; Huennekens FM
    J Med Chem; 1975 May; 18(5):526-8. PubMed ID: 807734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dihydrofolate reductase activity of leukemia L1210 during development of methotrexate resistance.
    Schrecker AW; Mead JA; Greenberg NH; Goldin A
    Biochem Pharmacol; 1971 Mar; 20(3):716-8. PubMed ID: 5150168
    [No Abstract]   [Full Text] [Related]  

  • 20. Polymorphism of dihydrofolate reductase from a methotrexate-resistant subline of L1210 cells.
    Duffy TH; Beckman SB; Sato JK; Nagae H; Vitols KS; Huennekens FM
    Adv Enzyme Regul; 1985; 23():3-12. PubMed ID: 4072799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.